Meningitis death toll highlights urgent need for enhanced vaccination efforts
Lancet report reveals continued global challenge with UK-specific data
Last updated 20 hours ago
A recent report from The Lancet Neurology underscores the ongoing global struggle against meningitis, revealing significant death tolls and calling for intensified vaccination and treatment efforts.
In 2023, meningitis accounted for 259,000 deaths globally, including 159 fatalities in the UK alone, as part of 5,150 reported cases. The World Health Organisation aims to reduce vaccine-preventable bacterial meningitis incidence by 50% and deaths by 70% by 2030 compared to 2015 figures. However, researchers argue that current progress is insufficient to meet these targets.
UK-specific data and global context
Detailed UK data indicates a division of fatalities between 84 men or boys and 75 women or girls. Though global deaths and cases have declined since 1990, experts emphasize the need for sustained momentum in combating meningitis.
Dr. Tom Nutt, CEO of Meningitis Now, asserts, “These findings are a stark reminder that meningitis remains a devastating global disease. Improving awareness and uptake of existing vaccines, alongside expanding eligibility where needed, will be critical if we are to prevent avoidable illness.”
Navigating challenges and increasing vaccination
Dr Shamez Ladhani of the UK Health Security Agency (UKHSA) underscores the importance of collaboration and expanded vaccine access to achieve WHO’s 'Defeating Meningitis by 2030' goals.
A recent Kent outbreak resulted in 20 confirmed meningitis cases, including the deaths of 18-year-old Juliette Kenny and a University of Kent student. The outbreak prompted urgent health warnings and testing to assess links to cases across the UK.
Amid the outbreak, Health Secretary Wes Streeting stressed the importance of vigilance to anticipate cases elsewhere, noting lab testing's role in identifying connections to the Canterbury outbreak.
The report advocates for continued international focus alongside UK efforts to prioritize vaccination, facilitate early diagnosis, and ensure rapid access to treatment, playing a critical role in protecting vulnerable populations.